Tag: trustee

Supplementing the notice of 17^th June 2025 on convening the meeting of bondholders of UAB “Orkela” (code 304099538, registered address at Jogailos st. 4, Vilnius, Lithuania; the Company) bond issue, ISIN code LT0000405961 (the Bonds) on 9 January 2025 at 10 AM, Vilnius time¹ (the Meeting), the trustee of the bondholders UAB "AUDIFINA" (code 125921757, registered address at A. Juozapavičiaus st. 6, Vilnius, Lithuania; the Trustee), has the following additional information about the upcoming Meeting.

FORM 8.3

FORM 8.3

FORM 8.3

VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and convertible debentures of the Company, as further described herein.

Palo Alto, California, June 30, 2025 (GLOBE NEWSWIRE) --  NMP Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Company’s initial business combination. In connection with the offering, $10.00 per unit will be deposited into a trust account with Continental Stock Transfer & Trust Company acting as trustee. Up to $300,000 of interest earned on the funds held in the trust account, in the aggregate, may be released to us to fund our working capital requirements.  In addition, we may withdraw interest earned on the trust to pay our income and franchise taxes, if any. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “NMPAU” beginning on July 1, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to trade on Nasdaq under the symbols “NMP” and “NMPAR,” respectively.

8.3

FORM 8.3

FORM 8.3